Influenza (Flu)

On this page:

Influenza vaccine is available at the Medical Centre.

FLUZONE® Consumer Medicine Information Summary

FLUZONE® Product Information

Adverse events following influenza vaccination

Post-vaccination symptoms may mimic influenza infection. None of the influenza vaccines available in Australia contain live influenza viruses, so they cannot cause influenza.

Injection site reactions

Injection site reactions occur in more than 10% of people who receive standard-dose influenza vaccine intramuscularly. These include:

  • induration
  • swelling
  • redness
  • pain

Studies directly comparing inactivated trivalent and quadrivalent formulations in children and adults showed that the safety profiles were similar.

Systemic adverse events

1–10% of people who receive standard-dose influenza vaccines will develop:

  • fever
  • malaise
  • myalgia

These adverse events may start a few hours after vaccination and may last for 1–2 days.

Immediate adverse events following influenza vaccination are very rare. They can include hives, angioedema or anaphylaxis.

Post-vaccination procedures

It is recommended that vaccinated persons are kept under observation for at the Medical Centre for at least 15 minutes post vaccination.

Paracetamol or ibuprofen may be recommended, as required, for fever or pain after vaccination.

Further information